Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014;58(2):1228-30.
doi: 10.1128/AAC.01993-13. Epub 2013 Dec 2.

Extended-spectrum-β-lactamase-producing Escherichia coli as intestinal colonizers in the German community

Affiliations

Extended-spectrum-β-lactamase-producing Escherichia coli as intestinal colonizers in the German community

Giuseppe Valenza et al. Antimicrob Agents Chemother. 2014.

Abstract

We determined the presence of extended-spectrum-β-lactamase (ESBL)-producing Escherichia coli among 3,344 study participants from the German community. Intestinal colonization was detected in 211 persons (6.3%), without significant differences among the different age groups. The majority (95.2%) of isolates harbored CTX-M-type ESBL, with CTX-M-15 (46%) and CTX-M-1 (24.2%) as the most common types. The finding of ESBL producers and one isolate additionally producing carbapenemase OXA-244 indicates a risk of dissemination of resistant bacteria outside the hospitals.

PubMed Disclaimer

References

    1. Cantón R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM. 2008. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 14:144–153. 10.1111/j.1469-0691.2007.01850.x - DOI - PubMed
    1. Rodríguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A. 2008. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J. Antimicrob. Chemother. 62:1142–1149. 10.1093/jac/dkn293 - DOI - PubMed
    1. Vidal-Navarro L, Pfeiffer C, Bouziges N, Sotto A, Lavigne JP. 2010. Faecal carriage of multidrug-resistant Gram-negative bacilli during a non-outbreak situation in a French university hospital. J. Antimicrob. Chemother. 65:2455–24558. 10.1093/jac/dkq333 - DOI - PubMed
    1. Strömdahl H, Tham J, Melander E, Walder M, Edquist PJ, Odenholt I. 2011. Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden. Eur. J. Clin. Microbiol. Infect. Dis. 30:1159–1162. 10.1007/s10096-011-1202-5 - DOI - PubMed
    1. Wickramasinghe NH, Xu L, Eustace A, Shabir S, Saluja T, Hawkey PM. 2012. High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK. J. Antimicrob. Chemother. 67:1108–1113. 10.1093/jac/dks018 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources